Growth Metrics

Scholar Rock Holding (SRRK) EBITDA Margin (2019 - 2022)

Scholar Rock Holding's quarterly EBITDA Margin came in at 24.3% in Q1 2022, up 56291.0% year-on-year from N/an in Q1 2021, and up 97.26% quarter-over-quarter from 887.85% in Q4 2021.

Scholar Rock Holding has reported EBITDA Margin for 4 years, with the latest figure at 24.3% in Q1 2022.

  • For the quarter ending Q1 2022, EBITDA Margin rose 56291.0% year-over-year to 24.3%; the trailing twelve-month figure through Dec 2022 stood at 407.77% (up 29287.0% YoY), and the FY2022 full-year result was 407.77%, up 29287.0% from the prior year.
  • EBITDA Margin for Q1 2022 stood at 24.3%, up from 887.85% in the prior quarter.
  • The five-year high for EBITDA Margin was 24.3% in Q1 2022, with the low at 887.85% in Q4 2021.
  • Average EBITDA Margin over 4 years is 486.51%, with a median of 499.13% recorded in 2020.
  • Year-over-year, EBITDA Margin tumbled 62078 bps in 2020 and jumped 56291 bps in 2022.
  • Tracing SRRK's EBITDA Margin over 4 years: stood at 152.67% in 2019, then sank by 407 bps to 773.46% in 2020, then slipped by 15 bps to 887.85% in 2021, then soared by 97 bps to 24.3% in 2022.
  • The last three EBITDA Margin figures came in at 24.3% (Q1 2022), 887.85% (Q4 2021), and 686.6% (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.35%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.24%
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -24.30%
Dec 31, 2021 -887.85%
Sep 30, 2021 -686.60%
Jun 30, 2021 -668.57%
Mar 31, 2021 -587.21%
Dec 31, 2020 -773.46%
Sep 30, 2020 -777.31%
Jun 30, 2020 -499.13%
Mar 31, 2020 -335.45%
Dec 31, 2019 -152.67%
Sep 30, 2019 -338.90%
Jun 30, 2019 -247.73%
Mar 31, 2019 -345.49%